DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Small Molecule Drugs cited in Ferring B v. v. Watson Laboratories Inc.
Biologic Drugs cited in Ferring B v. v. Watson Laboratories Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2014-05-01||27||6,051,253 A 4/2000 Zettler 6,066,339 A 512000 Stark et al. …may be divided into three doses of 6,066,339, which is expressly incorporated by reference … EXHIBIT~ 6,066,339 A 5/2000 Stark et al. …doses. As an example, a total daily dose 35 6,066,339, which is expressly incorporated by reference …infringement of the patents-in-suit in this case as well as a related patent, U.S. Patent No. 8,478,005.||External link to document|
|2014-05-14||40||Ferring’s U.S. Patent Nos. 7,947,739 (“the ’739 patent”), 8,022,106 (“the ’106 patent”) and 8,273,795…The Asserted Patent Claims Claim 1 of the ’739 patent is illustrative of the patent claims at issue…regarding the patents at issue in this appeal, and an infringement claim regarding a different patent. …as Example 1 of the patents-in-suit, and its own ANDA documents and patent application detail …the asserted patent claims, and also meet the dissolution limitations of the patent claims. 3||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|